Pharmafile Logo

Electronic medical records and doctor/patient communication

April 2, 2015 |  

View from the US: When I talk to family members or friends who are physicians these days, I hear a lot of complaints.

What seems to get US doctors I talk to most agitated is an aspect of Obamacare that gets relatively little attention outside the healthcare community:  the “forced” conversion of medical practices to electronic medical records (EMR).
Under legislation signed in 2009, physicians were given a January 2015 deadline to convert to EMR and show “meaningful use” of these systems or face lower reimbursement rates on Medicare physician fees – a penalty of 1 percent of Medicare payments, increasing to 2 percent in 2016 and 3 percent in 2017.  To help offset the cost of EMR conversion, the federal government is offering individual practitioners up to $44,000 in incentive payments under the American Recovery and Reinvestment Act.  With both a carrot and a stick in place, physician practices, large and small, have been converting en masse.  

For many US physician practices, implementing EMR software and converting paper patient records to electronic form has been massively disruptive, as well as costly.  My own primary care practice, a small physician group, cut back on the number of patients seen per day for several months while their doctors and staff learned the new system.
Even with the financial and administrative challenges, what some doctors find to be the most difficult aspect of the conversion to EMR is the way it impacts the daily practice of medicine by changing how they communicate with patients, and thus altering the doctor-patient relationship.  With increasing time pressures, some clinicians feel they need to type into their computer or tablet while talking to patients, their face buried in the screen.  Many  find this takes their focus away from what the patient is saying, and leads them to miss picking up on some cues, or gaining a more holistic understanding of the patient.  On the other hand, some believe the greater access to information through the EMR system, and elimination of the need to scan through paper records, improves patient care.

A 2008 study conducted by the Center for Studying Health System Change found EMR systems both help and hinder communication between doctors and patients, as well as clinician-clinician interactions.  As system designs improve and physicians gain increasing familiarity with the technology, the positives should outpace the negatives.  Certainly, for the new generation of physicians (like my daughter, who is a third year medical student), who are learning the practice of medicine with these tools, the use of EMR should be second nature.

As a market researcher, who has seen MR evolve from largely face-to-face to largely web-based, I wonder if there are parallels for our industry…  Is our evolving technology promoting or hindering engaging in dialogue with respondents?  It certainly is possible for researchers to be distracted by the “latest and greatest” technological innovation in MR.  The key is to be able to leverage our technology to gain richer insights and understanding, not simply more data.

Research Partnership is one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. Find out more here: http://bit.ly/1FbCHZG

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: Therapy Watch Lupus

Download our latest infographic, which offers an introduction to the real-world patient insights collected by our Therapy Watch Lupus study.

Article: Getting their lives back: Improving options for people with Lupus

Head of Therapy Watch, Helen Parfitt and Head of Living With, Mariel Metcalfe, investigate Lupus from the perspective of both healthcare professionals and patients using data from our syndicated products.

MedTech specialist joins Research Partnership

Janet Powers has joined the company as a Director in the MedTech division.

Interactive: Best Behaviour

Download our curated collection of case studies and other useful resources that illustrate how we apply the principles of behavioural science in our research design.

RP Investigates – Q&A session: Living with Lupus

In this 45-minute session, Head of Living With, Mariel Metcalfe spoke to Brenda, who was diagnosed with Lupus 12 years ago.

Webcast: Demand Assessment

Find out how a study design which better reflects real-world choices can produce a more realistic model for the future market.

White paper: Are we prepared for the influx of CAR-Ts?

Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

New syndicated patient report – Living with Lupus US

Living with Lupus US is a new syndicated patient report which offers valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs.

Video: Emotion AI

Artificial intelligence is revolutionising the way we conduct healthcare market research.

Report: Mexico’s drug market access landscape shake-up: What does it mean for pharma?

Rebeca Nana Barrantes and Tania Rodrigues outline what the shake-up in Mexico’s drug market access landscape means for pharma.